Fraunhofer-Gesellschaft, headquartered in Munich, Germany, is Europe's leading organization for applied research. With over 75 institutes and research units across Germany, each focusing on different fields of science and technology, Fraunhofer drives innovation in sectors such as health, security, communication, energy, and environment. The organization's commitment to applied research fosters collaborations with industry, service sectors, and public administration, translating scientific findings into practical applications and promoting technological advancement globally.
Fraunhofer developed the RNAuto platform to help pharmaceutical developers scale mRNA-based drug production while integrating quality control into the manufacturing process.
From April 21 to 23, in Berlin, the Fraunhofer-Gesellschaft will present advanced AI solutions and data-driven technologies designed to enhance medical decision-making and streamline healthcare documentation.
Fraunhofer researchers are developing an interactive assistance system to improve female mortality rates after cardiac events by integrating biosensors and AI-based history recording.
Miniaturized pattern-scanning module enables precise beam control for ophthalmology and portable optical systems, improving treatment efficiency and system integration.
gammaSTAR platform and SpinIt project support manufacturer-independent MR sequence development and medical device certification for accelerated MRI examinations.
Fraunhofer Researchers are developing a camera-based system that automatically records the spatial position and angle of ultrasound scans on the patient’s body.
Researchers created silver-doped porous titanium surfaces using micro-arc oxidation, enabling rapid antibiotic loading and controlled release to reduce post-surgical infections.